Oculocutaneous Albinism

Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders of the pigment system in which production of melanin in the skin, hair and eyes is reduced or absent. At the molecular level, OCA is caused by compound heterozygous or homozygous mutations in genes that encode key enzymes or transport proteins of the melanosome.

OCA1 results from mutations in TYR, causing a deficiency of tyrosinase, the enzyme that controls the rate-limiting step converting tyrosine to DOPAquinone. OCA2, the most common type, results from mutations in OCA2, which encodes the P protein (an ion channel that regulates pH inside the melanosome). OCA3 and OCA4 are linked to mutations in TYRP1 and SLC45A2, respectively. Although people with OCA have a completely normal number of melanocytes, the severe lack of eumelanin (the dark, protective pigment) leaves the skin without its natural UV filter. The result is rapid photoaging and a very high risk of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).

At Haute-Derma, we have built a dedicated management and protection program for people with albinism. For skin that has no protective pigment of its own, we act as a comprehensive medical light shield, combining in-depth digital skin cancer screening with medical regimens that help preserve the skin's structure against sun damage.

Our Specialist Approach to Managing Albinism at Haute-Derma

Because the skin is extremely sensitive to light (extreme photosensitivity) and cannot protect itself, care at Haute-Derma follows strict clinical principles:

Early skin cancer screening and intervention (oncological interception): Ongoing monitoring of vessel patterns and growing epidermal lesions so that precancerous changes (actinic keratoses) can be found and treated at a microscopic stage.
Multi-layered photoprotection: Beyond sunscreen on the surface, the plan includes oral biological agents that strengthen skin cells' resistance to oxidative stress.
Pigment-targeting technologies are strictly contraindicated: We never use pigment lasers (such as Q-switched Nd:YAG, ruby or alexandrite) or broad-spectrum light therapies, which can cause serious thermal burns because the tissue lacks melanin to regulate energy absorption.

Screening and Clinical Risk Stratification at Haute-Derma

To care fully for skin affected by albinism, Haute-Derma carries out regular in-depth checks:

Digital total body mapping: High-magnification digital dermoscopy is used to photograph and store images of the entire skin surface. This helps detect amelanotic nevi or suspected carcinomas at a very early stage, based on their vessel morphology.
Phenotype assessment and genetic subtype: Recording the color of the iris, hair and skin (from the snow-white of OCA1A to the yellow or light brown of OCA2 and OCA3) to estimate how much pheomelanin and eumelanin remains, and from that to grade the risk of UV damage.
Biopsy and special stains: Thickened, scaly patches or non-healing sores are sampled with a punch biopsy. The specimen is stained with Masson-Fontana (a silver stain specific for melanin granules) to measure how much pigment is present in the basal keratinocytes and to distinguish the lesion clearly from other malignancies.
Coordinated specialist eye care: Referral for assessment of nystagmus, strabismus, photophobia and especially foveal hypoplasia, which always accompanies OCA.

Clinical Management and Skin Cell Protection at Haute-Derma

Our treatment strategy aims to give keratinocytes the best chance of survival and to repair tissue damage:

High-level photoprotection plan: Medical-grade broad-spectrum sunscreens with SPF ≥ 50 and PPD ≥ 16, preferably with micronized mineral filters (zinc oxide and titanium dioxide) that reflect UVA and UVB fully. This is combined with oral Polypodium leucotomos (a fern extract) and nicotinamide (vitamin B3) to help repair UV-induced DNA damage and lower the risk of non-melanoma skin cancer.
Definitive treatment of actinic keratoses (AK): For AK papules (precancerous lesions), Haute-Derma uses targeted liquid nitrogen cryotherapy or prescribes topical imiquimod 5% or 5-fluorouracil (5-FU), which stimulate a local immune response that selectively destroys the abnormal epidermal cells.
Gentle repair of sun-damaged skin (solar elastosis): To improve rough texture and deep wrinkles caused by sun-damaged collagen, we use non-ablative fractional laser (1565 nm) at low energy. It safely stimulates new collagen bundles without harming the already very fragile epidermal barrier of people with OCA.

Frequently Asked Questions About Albinism

+If people with albinism have a normal number of melanocytes, why does their skin have no color?

This is a key point of pathology. Albinism is not a disease of melanocyte loss (as vitiligo is). In OCA, melanocytes are present in the basal layer of the epidermis in normal numbers. However, because of gene mutations (such as in TYR), the "factory" inside these cells lacks the enzymes or proteins needed for the chain of chemical reactions that turns tyrosine into melanin. The pigment packages (melanosomes) are made but stay empty, with no color to pass on to the surrounding keratinocytes.

+Why is squamous cell carcinoma (SCC), rather than melanoma, the most common and dangerous cancer in people with albinism?

In the general population, melanoma is the most dangerous skin cancer. In people with albinism, however, squamous cell carcinoma (SCC) is the most common and appears at a very young age. OCA skin has essentially no eumelanin to absorb UVB, so UVB strikes the DNA of keratinocytes in the spinous and basal layers directly and repeatedly, causing characteristic mutations in the tumor suppressor gene TP53. As these mutations build up, actinic keratoses form and then quickly progress to invasive SCC.

+What is amelanotic melanoma in people with albinism, and why is it a dangerous clinical trap?

Amelanotic melanoma is a very rare and dangerous form of melanoma that arises from the non-pigment-producing melanocytes of a person with albinism. Ordinary melanomas are black or brown because they contain melanin, which makes them easy for doctors to spot. In OCA, though, the tumor may look like nothing more than a pale pink, red or skin-colored bump, much like a harmless sore, a skin tag or a BCC. This "trap" means the lesion is easily missed, so it is often diagnosed late, after it has already spread through the lymphatic system.

+Why do vision problems (such as light sensitivity and poor eyesight) always come with the skin changes in oculocutaneous albinism?

The link comes from the shared embryonic origin of the pigment system. During fetal development, melanin is not only made in the skin; it also plays a decisive structural role in the retinal pigment epithelium (RPE) and the iris. Melanin in the eye is needed to guide the optic nerve fibers from the retina so they cross correctly at the optic chiasm on their way to the brain, and to help the fovea form fully. Without melanin, the nerve fibers are misrouted and the fovea is underdeveloped (hypoplastic). This causes permanent visual problems such as strabismus, nystagmus and severely reduced vision, quite separate from the loss of skin protection.

Oculocutaneous Albinism

Our Specialist Approach to Managing Albinism at Haute-Derma

Screening and Clinical Risk Stratification at Haute-Derma

Clinical Management and Skin Cell Protection at Haute-Derma

Frequently Asked Questions About Albinism

Experiencing similar symptoms?

Nhắn tin cho phòng khám